All Articles

The 40th anniversary of the San Antonio Breast Cancer Symposium was attended by approximately 8000 healthcare professionals and featured presentations ranging from basic science to preliminary clinical trials and new standards of care. Below is a summary of key presentations featured at the press conferences.

The current US Preventive Services Task Force guidelines call for breast cancer screening every 2 years for women between the ages of 50 and 75 years.

Older patients with hormone receptor–positive, HER2-negative, metastatic breast cancer derive similar benefit as younger patients treated with CDK4/6 inhibitors as part of initial endocrine therapy, according to a pooled analysis of registration trials presented at the 2017 San Antonio Breast Cancer Symposium.

The beginnings of the Academy of Oncology Nurse & Patient Navigators (AONN+) were based on empiric knowledge that navigating patients through the maze of cancer care improves their clinical outcome as well as their experience.

This report evaluates the quality of that evidence and provides a plain language review of the statistics regarding the efficacy of High-Potency Polymerized Cross-linked Sucralfate as well as the inherent limitation of some guideline-supported therapies.

The survivorship care plan (SCP) is used to assist cancer survivors with the transition from active treatment to the survivorship phase; all nurses play a significant role in the delivery of this vital aspect of survivorship care.

Poor health literacy can lead to poor health outcomes. Helping patients to comprehend complex health information decreases their risk of negative outcomes while providing an optimal approach to patient-centered care.

To advance quality patient care and ensure all parties are working toward a common goal, navigators must integrate with oncology/hematology physician practices. At the AONN+ 8th Annual Navigation & Survivorship Conference, Tricia Strusowski, RN, MS discussed approaches to integration.

As the number of patients receiving immune checkpoint blockade grows, the combination of radiation and immunotherapy has become increasingly relevant, particularly in the palliative care setting, where radiation is used to treat painful lesions, brain metastases, or isolated progression.

The prevalence of fatigue is very high across the cancer continuum, with approximately 60% of advanced cancer patients experiencing this condition.